Skip to main content
Equibles
GH logo

GH · Guardant Health, Inc. · Investor Relations

Track GH — free

Use GH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$157.67 +6.80 (+4.50%) Play latest call Q3 2026 earnings call transcript
Russell 1000 member Rebalance outlook locked
Market Cap
$20.41B
Shares
135.29M
Volume · Nov 9 682.38K Avg daily vol (3M) 1.99M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-11-05 Guardant Health Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
2026-11-03 Kevin Sayer Joins Guardant Health Board of Directors
2026-11-03 Guardant Health Wins 2026 Prix Galien USA Award for Best Medical Technology for Shield Blood Test
2026-10-29 Guardant Health Applauds New Law Ensuring Access to Colorectal Cancer Screening Innovations with No Cost-Sharing for Pennsylvanians
2026-10-20 Guardant Health Highlights Broad Liquid Biopsy Research Portfolio at ESMO Congress 2026
2026-10-15 Guardant Health Shield Blood Test Demonstrates Leading Screening Adherence and CRC Deaths Averted Compared to Stool-Based Tests
2026-10-08 Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced ER-positive Breast Cancer
2026-10-08 Guardant Health to Report Third Quarter 2026 Financial Results on November 5, 2026
2026-10-05 Guardant Health COSMOS Study Published in Cancer Research Communications Validates Utility of Guardant Reveal® Liquid Biopsy Test for Predicting Recurrence in Melanoma
2026-09-14 Guardant Health’s Shield Blood Test Covered by EviCore by Evernorth for Colorectal Cancer Screening
2026-09-09 Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer
2026-09-08 Business Insider Names Guardant Health One of America's Most Innovative Businesses
2026-09-04 Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced Breast Cancer
2026-09-01 Guardant Health’s Shield Blood Test Covered by Carelon Health Services for Colorectal Cancer Screening
2026-08-24 Guardant Health to Appeal Federal District Court Judgment
2026-08-10 Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-30 Guardant Health Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
2026-07-29 Guardant Health to Participate in Upcoming Investor Conferences
2026-07-28 Actor and Cancer Advocate Patrick Dempsey Stars in Emotional Tribute Video From Guardant Health Memorializing Those Who Have Lost Their Lives to Colorectal Cancer
2026-07-09 Guardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026
2026-07-01 UnitedHealth Group Now Covers Guardant Health’s Shield Blood Test for Colorectal Cancer Screening
2026-06-11 Guardant Health Announces FDA Approval of Guardant360 CDx as Companion Diagnostic for Boehringer Ingelheim’s HERNEXEOS®
2026-05-28 Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting
2026-05-27 American Cancer Society Recommends Guardant Health’s Shield Blood Test in Updated Colorectal Cancer Screening Guidelines
2026-05-20 FDA Approves New Guardant360 Liquid CDx, the Largest FDA-Approved Liquid Biopsy Panel with a 100x Expanded Footprint

Past events

Date Event Type
2026-11-05 Guardant Health Q3 2026 Earnings Call Earnings call
2026-09-15 Morgan Stanley 24th Annual Global Healthcare Conference Conference
2026-08-12 Canaccord Genuity 46th Annual Growth Conference Conference
2026-07-30 Guardant Health Q2 2026 Earnings Call Earnings call
2026-06-17 2026 Annual Meeting of Stockholders Shareholder meeting
2026-06-03 Jefferies 2026 Global Healthcare Conference Conference
2026-06-02 William Blair 46th Annual Growth Stock Conference Conference
2026-05-12 BofA Securities 2026 Healthcare Conference Conference
2026-05-07 Guardant Health Q1 2026 Earnings Call Earnings call
2026-03-11 Barclays 28th Annual Global Healthcare Conference Conference
2026-03-10 Leerink Partners Global Health Conference Conference
2026-03-04 TD Cowen 46th Annual Health Care Conference Conference
2026-02-19 Guardant Health Q4 and Full Year 2025 Earnings Call Earnings call
2026-02-10 BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference Conference
2026-01-12 44th Annual J.P. Morgan Healthcare Conference Conference
2025-12-02 Piper Sandler 37th Annual Healthcare Conference Conference
2025-11-19 Jefferies Global Healthcare Conference Conference
2025-10-29 Guardant Health Q3 2025 Earnings Call Earnings call
2025-09-24 Guardant Health 2025 Investor Day Presentation
2025-09-08 Morgan Stanley 23rd Annual Global Healthcare Conference Conference
2025-08-13 Canaccord Genuity 45th Annual Growth Conference Conference
2025-07-30 Guardant Health Q2 2025 Earnings Call Earnings call
2025-06-09 Goldman Sachs 46th Annual Global Healthcare Conference Conference
2025-06-04 Jefferies Global Healthcare Conference Conference
2025-05-14 BofA Securities 2025 Healthcare Conference Conference

Source: https://investors.guardanthealth.com/overview/default.aspx

Key facts CIK 1576280 CUSIP 40131M109 13F (30d) 297 filings 264 filers Visit website Investor relations